Status and phase
Conditions
Treatments
About
This is a multicenter, open-label study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon in treating sleep disturbances in pediatric and adult participants with ASD.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
100 participants in 1 patient group
Loading...
Central trial contact
Vanda Pharmaceuticals Inc.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal